Ask AI

A Master Class in CP-CML: New Agents, Treatment Goals, and Clinical Challenges

Gain expert insights into evidence-based individualized approaches for frontline treatment of chronic-phase CML and how to incorporate molecular and mutational monitoring to optimize individualized patient outcomes through a certified on-demand webcast, expert-authored ClinicalThought commentary, and accompanying downloadable slides.

Share

Program Content

Events

Activities

CP CML Frontline TKIs
Evolving Standard of Care for Frontline TKI Therapy in CP-CML Clinical Practice
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 03, 2025

CP-CML: TKI Intolerance
Grappling With First-line Treatment Intolerance in CP-CML: What Are the Next Best Options for Patients?
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 03, 2025

Monitoring Response in CP CML
Optimal Risk Assessment, Response Monitoring, and Testing for TKI Resistance in Patients With CP-CML
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 03, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation